OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
APTA$0.5654

Aptamer Group PLC

Advanced Medical Equipment & TechnologyVerified

Aptamer Group PLC has a market capitalization of £191.76 million with a market price of £0.555 per share. The company has 3.46 billion shares outstanding, with no dilution observed between basic and diluted shares. No liquidity metrics are available due to missing balance-sheet inputs and lack of going-concern language in source documents. The company's profitability and return metrics are not available in the valuation snapshot, precluding a direct comparison to industry_config preferred metrics or cohort medians. Without revenue, EBITDA, or net income data, it is not possible to assess margins, ROIC, or other key performance indicators. Aptamer Group PLC does not disclose segment or geographic revenue breakdowns in the available data, making it impossible to evaluate revenue concentration or geographic exposure. No growth trajectory can be determined from the outlook data, as no numeric deltas or revenue history are provided. The risk assessment indicates low dilution potential, with no near-term dilution pressure observed. However, liquidity risk could not be assessed due to missing balance-sheet inputs and no going-concern language in source documents. No recent events, filings, or transcripts are available in the provided data to inform the company's current operational or strategic developments.

30-day price · APTA(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyAptamer Group PLC
TickerAPTA.L
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. Aptamer Group PLC develops and commercializes aptamer-based diagnostic and therapeutic products for the healthcare industry.

Classification. Aptamer Group PLC is classified in the Healthcare Services & Equipment business sector under the Advanced Medical Equipment & Technology industry with 92% confidence.

Aptamer Group PLC has a market capitalization of £191.76 million with a market price of £0.555 per share. The company has 3.46 billion shares outstanding, with no dilution observed between basic and diluted shares. No liquidity metrics are available due to missing balance-sheet inputs and lack of going-concern language in source documents. The company's profitability and return metrics are not available in the valuation snapshot, precluding a direct comparison to industry_config preferred metrics or cohort medians. Without revenue, EBITDA, or net income data, it is not possible to assess margins, ROIC, or other key performance indicators. Aptamer Group PLC does not disclose segment or geographic revenue breakdowns in the available data, making it impossible to evaluate revenue concentration or geographic exposure. No growth trajectory can be determined from the outlook data, as no numeric deltas or revenue history are provided. The risk assessment indicates low dilution potential, with no near-term dilution pressure observed. However, liquidity risk could not be assessed due to missing balance-sheet inputs and no going-concern language in source documents. No recent events, filings, or transcripts are available in the provided data to inform the company's current operational or strategic developments.
Key takeaways
  • Aptamer Group PLC operates in the Advanced Medical Equipment & Technology industry with 92% classification confidence.
  • The company has a market capitalization of £191.76 million and 3.46 billion shares outstanding.
  • No liquidity metrics are available due to missing balance-sheet inputs and lack of going-concern language in source documents.
  • No profitability, growth, or segment data is available in the provided financial snapshot.
  • The company is assessed to have low dilution risk, but liquidity risk remains unassessable.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyGBP
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$1.6M-$2.9M-$2.3M
FY-3$4.0M-$2.6M-$2.1M-$2.1M
FY-2$1.8M-$8.2M-$7.8M-$9.1M
FY-1$860.0k-$3.1M-$3.0M-$2.8M
FY0$1.2M-$2.5M-$2.4M-$2.3M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$2.1M$105.5k
FY-3$11.5M$8.1M
FY-2$2.8M$304.0k
FY-1$2.8M$887.0k
FY0$2.8M$1.4M
PeriodOCFCapExFCFSBC
FY-4-$1.4M-$424.3k
FY-3-$2.4M-$418.0k-$2.1M
FY-2-$4.1M-$2.0M-$9.1M
FY-1-$2.3M-$122.0k-$2.8M
FY0-$1.9M-$92.0k-$2.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price$0.56
Market cap$1.92B
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Healthcare Equipment · cohort 91 companies
MetricAPTAActivity
Op margin-16.5% medp25 -174.5% · p75 8.8%
Net margin-16.5% medp25 -172.4% · p75 8.4%
Gross margin47.4% medp25 34.2% · p75 65.3%
CapEx / revenue-5.4% medp25 -12.5% · p75 -2.2%
Debt / equity4.3% medp25 0.0% · p75 28.0%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 01:29 UTC#f8f9cd8b
Market quoteclose GBP 0.60 · shares 3.46B diluted
no public URL
2026-05-08 01:29 UTC#2a1f8608
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 09:16 UTCJob: 625bc4b5